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22 Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB) and has evolved an incredible 
23 ability to survive latently within the human host for decades. The Mtb pathogen encodes for a low number of 
24 ATP-binding cassette (ABC) importers for the acquisition of carbohydrates that may reflect the nutrient poor 
25 environment within the host macrophages. Mtb UgpB (Rv2833) is the substrate binding domain of the 
26 UgpABCE transporter that recognises glycerophosphocholine (GPC), indicating that this transporter has a role 
27 in recycling glycerophospholipid metabolites. By using a combination of saturation transfer difference (STD) 
28 NMR and X-ray crystallography we report the structural analysis of Mtb UgpB complexed with GPC and have 
29 identified that Mtb UgpB does not only recognise GPC but that it is promiscuous for a broad range of 
30 glycerophosphodiesters. Complementary biochemical analyses and site-directed mutagenesis precisely define 
31 the molecular basis and specificity of glycerophosphodiester recognition. Our results provide critical insights 
32 into the structural and functional role of the Mtb UgpB transporter and reveal that the specificity of this ABC-
33 transporter is not limited to GPC therefore optimising the ability of Mtb to scavenge scarce nutrients and 
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38 Bacterial pathogens have evolved a wide range of strategies to survive and thrive within their host 
39 environment. The ability to assimilate nutrients is vital and pathogens have evolved diverse strategies to uptake 
40 and scavenge the scarce energy sources that are available to them. In the context of intracellular microbial 
41 infections there is growing evidence that in a nutrient limited environment the interplay between the host and 
42 the pathogen is important. This is manifested through the ability of bacterial pathogens to utilise discrete 
43 nutrient sources with dedicated transport machinery for import. Glycerophosphodiester metabolites that are 
44 released by the action of phospholipases on host phospholipids represent an important nutrient source for the 
45 supply of carbon and phosphate.  
46
47 Mycobacterium tuberculosis (Mtb) is a major human pathogen and is now the leading cause of death from a 
48 single infectious agent worldwide, resulting in more deaths each year than HIV and malaria combined1. Mtb 
49 is a highly evolved pathogen that is able to persist and survive intracellularly within macrophages for decades2. 
50 However, the essential nutrients that are available to Mtb within the stringent environment of the human host 
51 and acquisition systems are poorly understood3-4. Understanding the molecular mechanisms that enable Mtb 
52 to survive within this niche environment and the nutrients that are assimilated is critical to understand this 
53 major global pathogen and for the development of new therapeutic approaches.
54
55 The sugars that are available within the nutrient-limited macrophage environment are unknown, however Mtb 
56 is equipped with five putative importers of carbohydrate substrates: four members of the ATP-binding cassette 
57 (ABC) transporter family and one belonging to the major facilitator superfamily3-4. Until recently the substrates 
58 for these transporters were unresolved, however, recent studies have demonstrated a role for the ABC-
59 transporters in the recycling of components from the complex Mtb cell wall. Trehalose is recycled from the 
60 Mtb cell envelope glycolipid trehalose monomycolate and taken up by the LpqY-SugABC transporter, which 
61 plays a critical role in the virulence of the Mtb pathogen5. The Mtb UspABC transporter has been found to 
62 recognise amino-sugars with a potential role in the uptake of Mtb cell-wall peptidoglycan fragments6. 
63
64 The role of the UgpABCE ABC-transporter is less clear, however studies of its substrate binding domain Mtb 
65 UgpB (Rv2833c) indicate its importance for Mtb survival and pathogenesis and in vivo Mtb UgpB has been 
66 found to be upregulated during infection7. Mtb UgpB has been shown to bind the glycerophosphocholine 
67 (GPC) head group of the membrane phospholipid phosphatidylcholine and metabolomic profiling by NMR of 
68 intact lung tissue at various stages of Mtb infection has revealed that the GPC metabolite increases significantly 
69 as infection progresses, with a concomitant decrease in phosphatidylcholine8. However, despite the essential 
70 role of this Mtb transporter, the molecular mechanisms that dictate how GPC is recognised and whether other 
71 glycerophosphodiester metabolites are substrates for this ABC-transporter are currently unknown. The only 
72 crystal structure of Mtb UgpB is of the protein in an open conformation without substrate bound (PDB 4MFI)9. 
73 Some mechanistic understanding of substrate recognition can be obtained from the crystal structure of a 
74 homologue from E. coli with low sequence identity (25%) in complex with glycerol-3-phosphate (G3P) (PDB 
75 4AQ4)10. However, Mtb UgpB does not bind G3P. Comparison of the closed G3P-bound E.coli UgpB with 
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76 the open Mtb UgpB in the absence of substrate (PDB 4MFI) reveals notable differences in the binding sites of 
77 these homologous proteins indicating that these UgpB ABC-transporters, belonging within the same structural 
78 classification (cluster D)11, have diverged to have different substrate specificities. This may reflect the 
79 nutritional requirements of the specific organism within different host environments and also the ability of 
80 bacteria to produce G3P extracellularly through the action of secreted glycerophosphodiesterases that 
81 hydrolyse glycerophopshodiesters12. Other microorganisms that import GPC have evolved to use either 
82 permeases or proton symporters that belong to the major facilitator superfamily indicating that 
83 glycerophosphodiester uptake is not limited to ABC-transporters13-14. It is likely that the divergence of 
84 transport systems for the import of glycerophosphodiesters reflects the evolutionary divergence and 
85 intracellular life-style of the pathogen and the metabolites available within its niche environment. 
86
87 In this study, we report a detailed functional and structural characterisation of the Mtb UgpB substrate binding 
88 domain of the ABC-transporter using a combination of biochemical and biophysical approaches. We report 
89 the first crystal structure of Mtb UgpB in complex with GPC and identify, in both solid and solution state, the 
90 molecular determinants of binding and critical features for glycerophosphodiester recognition. Structure 
91 guided-mutagenesis has revealed the crucial role of binding-site residues that underpin substrate binding and 
92 function. Moreover, we show that Mtb UgpB has a broad selectivity for glycerophosphodiesters which 
93 highlights that the Mtb UgpABCE transporter uptakes metabolites derived from various glycerophospholipids. 
94 Thus, Mtb has evolved to use a broad spectrum of nutrients via a single ABC-transporter that enables it to 
95 adapt and assimilate essential nutrients during intracellular infection. 
96
97
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98 RESULTS AND DISCUSSION
99 Production of Mtb UgpB. An N-terminal truncated Mtb UgpB, corresponding to removal of residues 1-34 
100 predicted to form a trans-membrane anchor-helix, was cloned into the pYUB1062 vector with a C-terminal 
101 hexa-histidine affinity tag and expressed in Mycobacterium smegmatis mc24517. Soluble Mtb UgpB protein 
102 was obtained and purified to apparent homogeneity using Co2+-affinity, anion exchange and size-exclusion 
103 chromatography (Supplementary Figure S1). The identity of the Mtb UgpB protein was confirmed by using 
104 in-gel trypsin digestion and analysis of the peptides by mass spectrometry.
105
106 Co-crystal structure of Mtb UgpB with GPC. Initial attempts to crystallize Mtb UgpB in the presence of 
107 GPC routinely resulted in crystals of UgpB in an open conformation with no ligand bound. Therefore, to 
108 overcome this we chemically modified the surface Mtb UgpB through reductively methylation and this resulted 
109 in crystals of UgpB in complex with GPC. The UgpB protein co-crystallized with GPC with four molecules 
110 in the asymmetric unit. Phases for the structure were determined by molecular replacement using each of the 
111 two domains from the apo-structure of Mtb UgpB (PDB 4MFI) as separate search models and the structure 
112 was refined at a resolution of 2.3 Å, to a Rwork of 20.6 % and Rfree of 25.6 %, Supplementary Table 1 for the 
113 data collection and refinement statistics. Structural superposition of each molecule of Mtb UgpB using 
114 PDBeFOLD15 indicates that each molecule within the asymmetric unit is equivalent, aligning with r.m.s.d of 
115 0.35 - 0.44 Å for 394-395 residues. The crystal packing and analysis of the packing interfaces using 
116 PDBePISA16 does not suggest that Mtb UgpB forms dimers or higher oligomers and is consistent with our 
117 analytical gel filtration studies where the protein behaves as a monomer in solution with an apparent molecular 
118 weight of 44 kDa (Supplementary Figure S1D). It is therefore likely that the monomer is the biologically 
119 relevant unit, consistent with substrate binding domains of other ABC-transporters17-18. 
120
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122 Figure 1. Crystal structure of Mtb UgpB. A) Surface representation of Mtb UgpB in complex with GPC. 
123 The two domains are highlighted, domain I (brown) and domain II (green). The GPC ligand is represented as 
124 spheres with dark gray carbon atoms.  B) Cartoon representation of Mtb UgpB in complex with GPC 
125 identifying the secondary structure elements. Domain I (brown), domain II (green) and the two hinge regions 
126 are highlighted in blue. The GPC ligand is represented as spheres with dark gray carbon atoms C) 
127 Superposition of Domain I of GPC Mtb UgpB co-complex (brown/green) with Domain I of apo Mtb UgpB 
128 (PDB 4MFI) (magenta/orange). D) Surface representation of the unliganded Mtb UgpB (PDB 4MFI) with the 
129 two domains colored magenta (Domain I) and orange (Domain II). 
130
131
132 Overall structure of the Mtb UgpB-GPC complex. Mtb UgpB comprises two  domains (Figure 1). 
133 Domain I (residues 1-154 and 307-365) consists of a five-stranded -sheet surrounded by 11 -helices and 
134 domain II (residues 155-306 and 366-436) of a four-stranded -sheet enclosed by 9 -helices. The two 
135 domains, or globular lobes, are connected via two flexible hinges that are formed between residues Arg152-
136 Pro155 and Ala290-Ala307. Relative to the apo crystal structure there is a 22o rotation of domain I relative to 
137 domain II about the interdomain screw-axis with three hinge/binding regions identified from DynDom 
138 analysis19 (residues 152-153, 304-306 and 362-372 (Supplementary Table S2)). This bending movement 
139 results in an almost two-fold reduction in the volume of the cavity from 1986 Å3 to 791 Å3, as determined by 
140 CAVER 20, which is in-line with the ‘Venus Fly-trap mechanism’ for other substrate-binding proteins17-18 that 
141 close when substrate is bound. Interdomain bridging and stabilisation of this closed conformation of the protein 
142 is centred around Arg385, which forms interdomain hydrogen bonds with Asp102 from domain I and Gln381 
143 from domain II. The individual domains of Mtb UgpB apo- and GPC co-complex structures align with r.m.s.ds 
144 of 0.57 Å and 0.75 Å for domains I and II respectively (over 178 atoms, Domain I and over 216 atoms, Domain 
145 II, PDBeFOLD16). In comparison, superposition of Mtb UgpB apo- and GPC co-complex structures align with 
146 a r.m.s.d. of 2.2 Å (over 385 residues) highlighting the importance of an interdomain conformational change 
147 mechanism for substrate recognition by Mtb UgpB.
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148 The ligand-binding site of Mtb UgpB. Well defined electron density for the GPC ligand in all Mtb UgpB 
149 molecules within the crystal unit was observed enabling the GPC ligand to be modelled in the Mtb UgpB 
150 binding-site (Supplementary Figure S2A). The GPC ligand is found in an identical position and orientation in 
151 each subunit (Supplementary Figure S2B). Notably, the electrostatic surface shows that GPC is buried in the 
152 prominent, acidic interface that is formed between the two domains of UgpB and makes contact to both. The 
153 GPC is precisely orientated within the binding cleft such that the glycerol moiety is buried at the base of the 
154 cavity, in close proximity to the flexible hinge region centred around Arg385, whilst the choline moiety extends 
155 outwards towards the solvent exposed channel entrance (Figure 2). 
156
157 The glycerol moiety is located between the side chains of Leu205 and Trp208 from domain II (Figure 2). The 
158 ring system of Trp208 lies approximately parallel to the C1, C2 and 2-hydroxy group of the glycerol moiety 
159 enabling -stacking interactions, whilst Leu205 is orientated perpendicular to this plane and provides 
160 additional stabilisation. There is an important network of hydrogen bonding interactions that anchors GPC in 
161 the binding-pocket. The side chain of Asp102, from domain I, is orientated to enable direct hydrogen bonding 
162 to both the 1- and 2-hydroxy groups of the glycerol moiety. Two residues that comprise the flexible hinge-
163 linkages are able to directly interact with GPC through the formation of additional hydrogen bond interactions 
164 between the side chain of Arg385 and the 1-hydroxy group and the backbone amide nitrogen atom of Gly306 
165 with the 2-hydroxy group respectively. The direct interaction of these flexible-hinge linkages with the GPC 
166 ligand may help to stabilise the UgpB-GPC complex in the closed conformation. The phosphate group of GPC 
167 is stabilised through hydrogen bond interactions with the side chains of Tyr78 and Tyr345 (domain I), Ser153 
168 (domain I), Ser272 (domain II) and the backbone amide of Gly306. It is striking that there are no direct or 
169 charged interactions between Mtb UgpB and the positively charged choline moiety, though this moiety is well-
170 defined in the electron density.
171
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173 Figure 2. The GPC binding site in Mtb UgpB. A) Illustration showing GPC with dark gray carbon atoms 
174 and selected Mtb UgpB amino acid residues in stick representation (coloured brown for residues within 
175 Domain I, and green for residues with Domain II.  B) Schematic diagram of the interactions of Mtb UgpB with 
176 GPC. Dashed lines (black) represent hydrogen bonding, thick dotted line (red) represents hydrophobic 
177 interactions
178
179 Comparison with the binding site of E. coli UgpB. Comparison with UgpB from E coli10 indicates that the 
180 overall architecture of these two periplasmic binding proteins in complex with substrate is similar, with a 
181 r.m.s.d. of 2.1 Å (PDBeFold15, target residues: 394, sequence identity 25 % (Supplementary Figure S3), PDB 
182 code 4AQ4), Fig. 3. Whilst Mtb was crystallised with GPC, the E coli protein was crystallised with G3P that 
183 we, as well as previous studies10, show does not bind to Mtb UgpB.  It is interesting to note that the binding 
184 mode of the G3P core of GPC resembles the situation found in the E. coli UgpB-G3P complex10, even though 
185 Mtb UgpB is unable to bind or recognise this smaller G3P ligand (Fig. 3B). However, whilst the substrate 
186 binding pocket of Mtb UpgB resembles that of E. coli UgpB there are several important differences. Notably, 
187 there are substitutions of critical residues involved in substrate binding. Leu205 is specific to Mtb and is 
188 replaced by a larger indole-side chain from a tryptophan residue (Trp169) in E. coli UgpB. In addition, Mtb 
189 UgpB Asp102 is replaced in E. coli UgpB by a glutamic acid residue (Glu66) (Fig. 3C). In this instance, the 
190 difference in the length of these acidic side-chains may influence substrate selectivity between the different 
191 organisms. Intriguingly, whilst the interaction with an arginine residue is conserved between Mtb and E. coli 
192 the arginine residues in the two proteins originate from different regions of the protein indicating an 
193 evolutionary divergence of these substrate-binding proteins. In addition, a narrowing of the E. coli UgpB 
194 binding cleft results from two different loop regions. One loop region (Gly221-Asp230) in domain II of E. coli 
195 UgpB linking -helices 10 and 11 narrows the substrate binding cavity as a result of a 5 Å translational shift. 
196 The difference in position of a second loop comprised of residues His8-Gly12 results in the translation of the 
197 first -helix of E. coli UgpB (residues 12-30) located in domain I by approximately 6 Å towards -helix 11 of 
198 domain II which further narrows the E. coli UgpB substrate binding channel (Fig. 3D/E). Comparison of the 
199 region at the entrance to the binding cleft reveals an expanded pocket for Mtb UgpB. It is of interest to note 
200 that in chain B of Mtb UgpB we observe an additional glycerol molecule located in this expanded pocket that 
201 is within 4 Å of the choline moiety of GPC (Supplementary Figure S4). A glycerol molecule is also present in 
202 the E. coli UgpB-G3P complex, though at a different position, indicating that for both proteins the binding 
203 pockets are larger than the recognised GPC substrate10. This may be functionally significant in substrate 
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208 Figure 3. Comparison of Mtb UgpB with E. coli UgpB. A) Superposition of the Mtb UgpB GPC complex 
209 structure (blue) with E. coli UgpB in complex with G3P (PDB 4AQ4) (brown). Loop regions that differ are 
210 highlighted in yellow and magenta. B) Close-up illustration showing the binding orientation of the GPC ligand 
211 and G3P ligand in stick representation (dark gray carbon atoms, GPC, cyan carbon atoms G3P) C) Close-up 
212 of the overlay of the binding-sites of GPC (Mtb) and G3P (E. coli). Selected residues are shown as sticks (Mtb 
213 blue, E. coli brown) and the font labelled in black (Mtb) and blue (E. coli). D) Surface representation of the 
214 Mtb UgpB GPC binding pocket with the GPC ligand in stick representation. E) Surface representation of the 
215 E. coli UgpB G3P binding pocket in the same orientation as D with the G3P ligand in stick representation.   
216
217 Solution saturation transfer difference (STD) NMR of Mtb UgpB with glycerophosphocholine. Given the 
218 apparent discrepancy between the lack of interactions formed between the choline moiety and its importance 
219 in binding, given that G3P lacking the choline moiety does not bind, we investigated binding in the solution 
220 state. We employed saturation transfer difference (STD) NMR to obtain quantitative maps of the ligand-protein 
221 complex in solution (Fig. 4)21.  Binding was detected for GPC and binding epitope mapping was obtained and 
222 analysed as described in the methods section22. The STD NMR signals and the GPC binding epitope and maps 
223 obtained are shown in Fig. 4. From the epitope map, the glycerol moiety of GPC is identified as the main 
224 recognition element showing the highest STD normalized values. In particular, the highest STD intensity 
225 values were observed for the protons in position 1 and 2 (H1G and H2G) of the glycerol moiety (Fig. 4A), 
226 with slightly lower intensity values for the protons in position 3 (H3G). The STD values decrease from the 
227 glycerol moiety to the choline group, indicating that the ligand-protein contacts are closer with the glycerol 
228 group than with choline. Intermediate and low STD NMR intensity values were observed for the protons in 
229 position 1 and 2 (H1C and H2C) while low intensity values were observed for the methyl groups from the 
230 choline moiety. A quantitative comparison of the NMR solution data with the X-ray structure of the complex 
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231 was carried out using CORCEMA-ST calculations23, as well as the newly developed method DEEP-STD 
232 NMR24 and the results are summarised in Fig. 4. An NOE R-factor25 of 0.25 was obtained when comparing 
233 the CORCEMA-ST calculated STD NMR intensities using the crystal structure with the experimentally 
234 obtained solution data. This indicates a very good agreement of the complex in solution state with the crystal 
235 structure. In order to probe for additional structural information in the solution state we then utilised differential 
236 epitope mapping by STD NMR (DEEP-STD NMR). This methodology allows us to gain information about 
237 the orientation of the ligand within the architecture of the binding site and indirectly gives information about 
238 the type of amino acids (aromatic, polar or apolar residues) surrounding the ligand in the bound state26. The 
239 DEEP-STD NMR factors clearly identified that the protons in position 3 of the glycerol moiety of GPC are 
240 orientated towards aliphatic amino acids whilst the protons in position 1 in the choline moiety are oriented 
241 toward aromatic residues (Fig. 4C). Based on the crystal structure of Mtb UgpB these residues can be mapped 
242 to Leu205, Tyr78 and Tyr345 respectively (Fig. 2). Notably, our data shows strong correlation for the 
243 molecular determinants of GPC ligand binding to Mtb UgpB to GPC in both solution and solid state. 
244
245
246 Figure 4. STD-NMR for Mtb with GPC. A) Experimental STD build up curves for the GPC/Mtb UgpB 
247 complex and the obtained epitope map of GPC/Mtb UgpB. B) STD in red bars obtained with a 4s saturation 
248 time while in blue bars the CORCEMA-ST calculated STD from the 3D crystallographic structure of the Mtb 
249 UgpB/GPC complex obtained for the same saturation time. RNOE factor 0.25. C) Differential epitope (DEEP)-
250 STD factors showing the type of amino acid that the protons of the GPC ligand are orientated towards. Protons 
251 orientated towards aliphatic residues are highlighted in blue and protons orientated towards aromatic residues 
252 are highlighted in magenta. 
253
254 Substrate specificity of Mtb UgpB. To establish the importance of both the polar head group and the glycerol 
255 moiety for substrate recognition binding we analysed the binding interactions of Mtb UgpB with G3P, the 
256 preferred substrate of E. coli UgpB, and phosphocholine by thermal shift analysis and microscale 
257 thermophoresis. In contrast to GPC, no binding interactions were observed for these smaller derivatives. Taken 
258 together with our structural studies, these results indicate that whilst the glycerol moiety is the main recognition 
259 element for Mtb UgpB and that there are minimal interactions with the polar head group, the entire 
260 phosphodiester moiety is critical for substrate recognition and binding. The lack of recognition of G3P by Mtb 
261 UgpB is consistent with the intracellular location of two putative Mtb glycerophosphodiesterase enzymes 
262 (GlpQ1, Rv3842c; GlpQ2, Rv03127c) that are predicted to degrade glyercophosphodiesters to produce G3P 
263 and the corresponding alcohol 27-28. In direct contrast E. coli secretes glycerophosphodiesterase enzymes to 
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264 enable the extracellular production of G3P and this is consistent with the ability of the periplasmic E. coli 
265 UgpB to recognise the G3P metabolite12. 
266
267
268 Figure 5. Structure of glycerophosphodiesters and derivatives probed in this study
269
270 Our structural studies in both the solid and solution state revealed that the GPC substrate interacts 
271 predominantly with Mtb UgpB through interactions with the glycerol backbone. The lack of specific 
272 interactions between the protein and the polar choline head group located at the entrance of the substrate 
273 binding pocket led us to speculate that Mtb UpgB may recognise alternative glycerophosphodiester analogues. 
274 To directly investigate the substrate specificity of Mtb UgpB we used microscale thermophoresis (MST) to 
275 analyse the binding interactions of other phosphodiester products formed from the lipolysis of membrane 
276 glycerophospholipids (Fig. 5). From the substrates tested, in each case we were able to detect binding for GPC, 
277 glycerophosphoserine (GPS), glycerophosphoethanolamine (GPE), glycerophosphoinositol (GPI) and 
278 glycerophosphoinositol-4-phosphate (GPI4P), (Table 1, Fig. 6). The measured Kd value for GPC was 
279 consistent with previous results obtained by isothermal titration calorimetry (ITC) 9. Notably, Mtb UgpB also 
280 binds and recognises GPE, GPS, GPI and GPI4P glycerophosphodiesters with binding affinities in the 
281 micromolar range (Table 1) with a preference for positively charged polar head groups. Together, this suggests 
282 that Mtb has evolved to have a single ABC-transporter to scavenge a range of glycerophosphodiesters within 
283 its nutrient poor intracellular environment. The preference for GPC could suggest that as phosphatidylcholine 
284 is the main glycerophospholipid in human lung tissue29 Mtb UgpB has evolved to recognise the most abundant 
285 glycerophosphodiester available within the host environment, with the potential to recognise and transport a 
286 spectrum of additional glycerophosphodiesters depending on the growth conditions and nutrient availability 
287 during intracellular infection that can subsequently be catabolised by Mtb pathways that are involved in polar 
288 head group recycling 27. Notably, these glycerophospholipids are also major constituents of the Mtb cell 
289 envelope 30-31 and further experiments are underway to elucidate whether the glycerophosphodiesters are 
290 derived from host- or Mtb-lipids. 
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292 Figure 6. Binding affinities for Mtb UgpB Binding of A) GPC, B) GPS, C) GPE and D) GPI4P to Mtb UgpB 
293 measured by microscale thermophoresis (MST). FNorm (%) is the normalized fluorescence signal of the 
294 change in MST signal. Error bars represent standard deviations from at least three independent experiments.
295
296 As a final evaluation for potential substrate promiscuity we screened a panel of carbohydrates and amino acids 
297 using a thermal shift assay and assessed the binding of putative ligands that resulted in a change in the melting 
298 temperature (Tm) of Mtb UgpB which can be indicative of binding. In total 37 potential substrates were probed, 
299 including trehalose which is known to be a substrate of the Mtb LpqY-SugABC ABC-transporter5, and we 
300 found that none of the ligands that were screened influenced the melting temperature (Supplementary Figure 
301 S5). It appears that although Mtb encodes for only five putative carbohydrate importers, each transport system 
302 has a defined substrate preference. Interestingly, these data indicate that the substrate binding-pocket of Mtb 
303 UgpB can efficiently accommodate glycerophosphodiesters but that it is not able to recognise other 
304 carbohydrates or amino acids. 
305
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306 Table 1: Binding data for Mtb UgpB
Enzyme Substrate Kd (M) Reference
Mtb UgpB GPC 3.6 ± 0.5 This study
Mtb UgpB GPS 14.9 ± 1.6 This study
Mtb UgpB GPE 74.7 ± 13.9 This study
Mtb UgpB GPI 1053.2 ± 313.4 This study
Mtb UgpB GPI4P 289.8 ± 54.1 This study
Mtb UgpB G3P - This study
Mtb UgpB phosphocholine - This study
Mtb UgpB Y78A GPC - This study
Mtb UgpB Y78A GPS - This study
Mtb UgpB Y78A GPE - This study
Mtb UgpB D102A GPC - This study
Mtb UgpB D102A GPS - This study
Mtb UgpB D102A GPE - This study
Mtb UgpB Ser153Ala GPC 309.8 ± 56.1 This study
Mtb UgpB S153A GPS 102.5 ± 16.4 This study
Mtb UgpB S153A GPE - This study
Mtb UgpB L205A GPC 161.7 ± 15.9 This study
Mtb UgpB L205A GPE 1360 ± 210
Mtb UgpB W208A GPC - This study
Mtb UgpB S272A GPC - This study
Mtb UgpB Y345A GPC - This study
Mtb UgpB R385A GPC - This study
Mtb UgpB GPC 27.3  2.0± 9
Mtb UgpB G3P - 9
Mtb UgpB Maltose - 9
Mtb UgpB L205W GPC - 9
Mtb UgpB L205W G3P - 9
E. coli UgpB GPC 5.1  0.3± 10
E. coli UgpB G3P 0.68  0.02± 10
307
308 (-) = no binding detected, standard deviations from at least three independent experiments
309 GPC: glycerophosphocholine, GPS, glycerophosphoserine, GPE: glycerophosphoethanolamine, GPI
310 Glycerophosphoinositol, GPI4P:glycerophosphoinositol-4-phosphate.  
311
312
313 STD NMR of Mtb UgpB with GPI4P . Next, to validate some of the MST-binding data we used STD NMR 
314 spectroscopy for a more in-depth investigation of GPI4P binding to Mtb UgpB. Again the glycerol moiety of 
315 GPI4P was the main recognition element with close contacts to Mtb UgpB. High STD NMR intensity values 
316 were also observed for the H1 and H2 protons of the inositol ring with intermediate STD-NMR values for H3 
317 and H4 protons and low values for H5 and H6 protons (Fig 7A, B). This differs from the situation of the choline 
318 head group of GPC where instead low STD intensities were observed. Furthermore, the DEEP-STD NMR 
319 maps reveal a slight modification in the binding orientation of the glycerol tail of GPI4P compared to GPC as 
320 protons in position 3 orientated towards aromatic residues this time. To gain 3D structural insights about this 
321 interaction we carried out docking calculations using Autodock Vina32 followed by validation using 
322 CORCEMA-ST calculations. An NOE R-factor of 0.31 was obtained by comparing the CORCEMA-ST 
323 calculated STD intensities from the best scored docked structure of GPIP4 bound to Mtb UgpB and the 
Page 13 of 25































































324 experimental STD values. This indicates a good agreement of the proposed docking structure of the Mtb 
325 UgpB/GPIP4 complex with the experimental STD NMR data. From Fig. 7 we can observe that the protons in 
326 position 3 (H3G) are oriented toward the aromatic residues, which was also determined from DEEP-STD 
327 factors analysis. Further, also the protons of inositol-phosphate moiety are in line with the observed orientation 
328 from DEEP-STD factor analysis. In fact protons H4I, H1G, H2G are oriented toward aliphatic residue Leu205, 
329 while protons H1I, H3G, H6I, H5I are oriented toward the aromatic residues Tyr78 and Tyr345, validating the 
330 proposed model structure with the experimental STD and DEEP-STD NMR data. These studies indicate that 
331 the size and charge of the glycerophosphodiester head group is critical in defining substrate selectivity and the 
332 binding orientation of the glycerol tail.
333
334
335 Figure 7. STD NMR of Mtb UgpB with GPI4P A) Experimental STD build up curve for the Mtb 
336 UgpB/GPIP4 complex and the obtained epitope map of GPI4P/Mtb UgpB. B) Differential epitope (DEEP)-
337 STD factors showing the type of amino acid that the protons of the GPI4P ligand are orientated towards. 
338 Protons orientated towards aliphatic residues are highlighted in blue and protons orientated towards aromatic 
339 residues are highlighted in magenta. C) Docked structure of the GPIP4 in the binding site of Mtb UgpB. GPI4P 
340 is in stick representation with the carbon atoms in yellow. The binding orientation of GPC obtained from the 
341 crystal structure is shown in stick representation with orange carbon atoms. D) Close-up overlay of the binding 
342 orientations of GPC (cyan carbon atoms) with GPI4P (yellow carbon atoms).
343
344 Activity of sequence variants. In order to complement our structural studies in both the solution and solid 
345 state and assess the significance of individual amino acids that were identified to be important in molecular 
346 recognition and binding we introduced single point mutations in eight individual residues that were suggested 
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347 to interact with the glycerophosphodiester ligands. In each case, we confirmed that the substituted alanine 
348 mutation was not detrimental to the correct folding of the protein by circular dichroism spectroscopy 
349 (Supplementary Figure S6). MST was used to determine the binding affinities of the Mtb UpgB protein with 
350 GPC and complete abrogation of binding was observed when Tyr78, Asp102, Trp208, Ser272, Tyr345 and 
351 Arg385 were individually replaced by an alanine, confirming the significance of these residues in substrate 
352 selectivity and importance in binding recognition. In contrast, binding of GPC was still observed when Ser153 
353 and Leu205 were replaced by alanine, with a corresponding 85- and 45-fold reduction in the Kd values 
354 respectively (Table 1), indicating that whilst these two individual residues are important for binding, they are 
355 not critical. Failure of these single-residue mutants to completely abolish binding reflects that multiple amino-
356 acids are involved in the interaction with GPC, as observed from the crystal structure. Previous studies that 
357 mutated Mtb UgpB Leu205 to a tryptophan residue to mimic the situation found in E. coli UgpB were 
358 detrimental for binding of GPC, indicating that the bulky indole side-chain cannot be tolerated in Mtb UgpB9 
359 and did not enable recognition of G3P. The distinct glycerophosphodiester-recognition of Mtb UgpB compared 
360 with E.coli UgpB indicates that the mycobacterial UgpB transporter has evolved to have unique specificity 
361 and function that is distinct from other UgpB proteins. 
362
363 In conclusion, to date, the nutrient requirements of Mtb during infection and the corresponding transport 
364 systems have not been fully elucidated. The structural and functional understanding of mycobacterial ABC-
365 transporters that import essential nutrients is an important step to understanding the mechanisms that support 
366 intracellular survival. Importantly, we have identified that the essential Mtb UgpABCE importer is linked with 
367 glycerophosphodiester uptake with wide substrate selectivity. For the first time, we have established the 
368 molecular determinants of the distinct substrate selectivity of the UgpB substrate binding protein from the Mtb 
369 pathogen that has important structural and functional differences with E. coli UgpB. We therefore propose a 
370 new role for the Mtb UgpABCE transporter in the uptake of glycerophosphodiesters generated from the 
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377 Procedures for cloning, protein expression, crystallization, X-ray data collection and refinement, STD-NMR 
378 experiments, docking, micro-scale thermophoresis, thermal shift assays and enzymatic synthesis of substrates 
379 in this study are described in the Supporting Information 
380
381 Accession codes
382 Coordinates and structure factors for Mtb UgpB have been deposited in the Protein Data Bank under accession 
383 code 6R1B. 
384
385 Associated content
386 The Supporting Information is available free of charge.
387
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